Characterization of a Novel PERK Kinase Inhibitor With Antitumor and Antiangiogenic Activity
Cancer Research - United States
doi 10.1158/0008-5472.can-12-3109
Full Text
Open PDFAbstract
Available in full text
Date
January 18, 2013
Authors
Publisher
American Association for Cancer Research (AACR)